Altered histone modifications in cancer

Advances in Experimental Medicine and Biology

Volumn 754, Issue , 2013, Pages 81-107

  Campbell, Moray J ^a   Turner, Bryan M ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE; HISTONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAD PROTEIN; MAX PROTEIN; MYC PROTEIN; NR PROTEIN; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CHROMATIN; CORRELATION ANALYSIS; EPIGENETICS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE LOCUS; GENE SILENCING; GENETIC CODE; HISTONE MODIFICATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; TRANSCRIPTION INITIATION; TRANSCRIPTION TERMINATION;

EID: 84869069947     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-9967-2_4     Document Type: Article

References (190)

1. Allis CD et al (2007) New nomenclature for chromatin-modifying enzymes. Cell 131: 633-636 (Pubitemid 350089969)
2. Turner BM (2005) Reading signals on the nucleosome with a new nomenclature for modi fi ed histones. Nat Struct Mol Biol 12:110-112
3. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ (1997) Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389:251-260 (Pubitemid 27406632)
4. Flaus A, Owen-Hughes T (2011) Mechanisms for ATP-dependent chromatin remodelling: the means to the end. FEBS J 278:3579-3595
5. Recouvreux P et al (2011) Linker histones incorporation maintains chromatin fi ber plasticity. Biophys J 100:2726-2735
6. Talbert PB, Henikoff S (2010) Histone variants - ancient wrap artists of the epigenome. Nat Rev Mol Cell Biol 11:264-275
7. Kouzarides T (2007) Chromatin modi fi cations and their function. Cell 128:693-705 (Pubitemid 46273577)
8. Ngara R, Ndimba R, Borch-Jensen J, Jensen ON, Ndimba B (2012) Identi fi cation and pro fi ling of salinity stress-responsive proteins in Sorghum bicolor seedlings. J Proteomics 75: 4139-4150
9. Zhang S, Roche K, Nasheuer HP, Lowndes NF (2011) Modi fi cation of histones by sugar beta-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated. J Biol Chem 286:37483-37495
10. Tan M et al (2011) Identi fi cation of 67 histone marks and histone lysine crotonylation as a new type of histone modi fi cation. Cell 146:1016-1028
11. Cosgrove MS (2007) Histone proteomics and the epigenetic regulation of nucleosome mobility. Expert Rev Proteomics 4:465-478 (Pubitemid 47347595)
12. Hyland EM et al (2005) Insights into the role of histone H3 and histone H4 core modi fi able residues in Saccharomyces cerevisiae. Mol Cell Biol 25:10060-10070 (Pubitemid 41572751)
13. Xu F, Zhang K, Grunstein M (2005) Acetylation in histone H3 globular domain regulates gene expression in yeast. Cell 121:375-385 (Pubitemid 40692298)
14. Masumoto H, Hawke D, Kobayashi R, Verreault A (2005) A role for cell-cycle-regulated histone H3 lysine 56 acetylation in the DNA damage response. Nature 436:294-298 (Pubitemid 41021284)
15. Vempati RK (2012) DNA damage in the presence of chemical genotoxic agents induce acetylation of H3K56 and H4K16 but not H3K9 in mammalian cells. Mol Biol Rep 39:303-308
16. Clemente-Ruiz M, Gonzalez-Prieto R, Prado F (2011) Histone H3K56 acetylation, CAF1, and Rtt106 coordinate nucleosome assembly and stability of advancing replication forks. PLoS Genet 7:e1002376
17. Watanabe S et al (2010) Structural characterization of H3K56Q nucleosomes and nucleosomal arrays. Biochim Biophys Acta 1799:480-486
18. Xie W et al (2009) Histone h3 lysine 56 acetylation is linked to the core transcriptional network in human embryonic stem cells. Mol Cell 33:417-427
19. Luger K, Richmond TJ (1998) The histone tails of the nucleosome. Curr Opin Genet Dev 8:140-146 (Pubitemid 28206276)
20. Ferreira H, Somers J, Webster R, Flaus A, Owen-Hughes T (2007) Histone tails and the H3 alphaN helix regulate nucleosome mobility and stability. Mol Cell Biol 27:4037-4048 (Pubitemid 47011001)
21. Lenfant F, Mann RK, Thomsen B, Ling X, Grunstein M (1996) All four core histone N-termini contain sequences required for the repression of basal transcription in yeast. EMBO J 15:3974-3985 (Pubitemid 26289807)
22. Ling X, Harkness TA, Schultz MC, Fisher-Adams G, Grunstein M (1996) Yeast histone H3 and H4 amino termini are important for nucleosome assembly in vivo and in vitro: redundant and position-independent functions in assembly but not in gene regulation. Genes Dev 10:686-699 (Pubitemid 26112423)
23. Dion MF, Altschuler SJ, Wu LF, Rando OJ (2005) Genomic characterization reveals a simple histone H4 acetylation code. Proc Natl Acad Sci USA 102:5501-5506 (Pubitemid 40530287)
24. Turner BM (1993) Decoding the nucleosome. Cell 75:5-8 (Pubitemid 23306015)
25. Turner BM, Birley AJ, Lavender J (1992) Histone H4 isoforms acetylated at speci fi c lysine residues de fi ne individual chromosomes and chromatin domains in Drosophila polytene nuclei. Cell 69:375-384
26. Kutateladze TG (2011) SnapShot: histone readers. Cell 146:842-842.e1
27. Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ (2007) How chromatin-binding modules interpret histone modi fi cations: lessons from professional pocket pickers. Nat Struct Mol Biol 14:1025-1040 (Pubitemid 350060344)
28. Liu Z et al (2010) Jmjd1a demethylase-regulated histone modi fi cation is essential for cAMPresponse element modulator-regulated gene expression and spermatogenesis. J Biol Chem 285:2758-2770
29. Canzio D et al (2011) Chromodomain-mediated oligomerization of HP1 suggests a nucleosome-bridging mechanism for heterochromatin assembly. Mol Cell 41:67-81
30. Kolasinska-Zwierz P et al (2009) Differential chromatin marking of introns and expressed exons by H3K36me3. Nat Genet 41:376-381
31. Kourmouli N et al (2004) Heterochromatin and tri-methylated lysine 20 of histone H4 in animals. J Cell Sci 117:2491-2501 (Pubitemid 38877845)
32. Ringrose L, Paro R (2007) Polycomb/trithorax response elements and epigenetic memory of cell identity. Development 134:223-232
33. Mateescu B, England P, Halgand F, Yaniv M, Muchardt C (2004) Tethering of HP1 proteins to chromatin is relieved by phosphoacetylation of histone H3. EMBO Rep 5:490-496 (Pubitemid 38745040)
34. Ernst J et al (2011) Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473:43-49
35. Kharchenko PV et al (2011) Comprehensive analysis of the chromatin landscape in Drosophila melanogaster. Nature 471:480-485
36. Rada-Iglesias A et al (2011) A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470:279-283
37. Korolev N, Lyubartsev AP, Nordenskiold L (2006) Computer modeling demonstrates that electrostatic attraction of nucleosomal DNA is mediated by histone tails. Biophys J 90: 4305-4316 (Pubitemid 43830879)
38. Perico A, La Penna G, Arcesi L (2006) Electrostatic interactions with histone tails may bend linker DNA in chromatin. Biopolymers 81:20-28
39. Takahashi YH et al (2011) Dot1 and histone H3K79 methylation in natural telomeric and HM silencing. Mol Cell 42:118-126
40. Jones B et al (2008) The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure. PLoS Genet 4:e1000190
41. Lee MG et al (2007) Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 318:447-450
42. Agger K et al (2007) UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449:731-734 (Pubitemid 47552088)
43. Pekowska A et al (2011) H3K4 tri-methylation provides an epigenetic signature of active enhancers. EMBO J 30:4198-4210
44. Robertson AG et al (2008) Genome-wide relationship between histone H3 lysine 4 monoand tri-methylation and transcription factor binding. Genome Res 18:1906-1917
45. Zeissig S et al (2007) Butyrate induces intestinal sodium absorption via Sp3-mediated transcriptional up-regulation of epithelial sodium channels. Gastroenterology 132:236-248 (Pubitemid 46108746)
46. Augenlicht LH et al (2002) Short chain fatty acids and colon cancer. J Nutr 132: 3804S-3808S (Pubitemid 35435069)
47. Tanaka Y, Bush KK, Klauck TM, Higgins PJ (1989) Enhancement of butyrate-induced differentiation of HT-29 human colon carcinoma cells by 1,25-dihydroxyvitamin D3. Biochem Pharmacol 38:3859-3865 (Pubitemid 19284038)
48. Cuezva JM et al (2002) The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res 62:6674-6681 (Pubitemid 35364137)
49. Racker E, Spector M (1981) Warburg effect revisited: merger of biochemistry and molecular biology. Science 213:303-307
50. Hsu PP, Sabatini DM (2008) Cancer cell metabolism: Warburg and beyond. Cell 134:703-707
51. Cavill R et al (2011) Consensus-phenotype integration of transcriptomic and metabolomic data implies a role for metabolism in the chemosensitivity of tumour cells. PLoS Comput Biol 7:e1001113
52. Su G, Burant CF, Beecher CW, Athey BD, Meng F (2011) Integrated metabolome and transcriptome analysis of the NCI60 dataset. BMC Bioinformatics 12(Suppl 1):S36
53. Sharon D, Chen R, Snyder M (2010) Systems biology approaches to disease marker discovery. Dis Markers 28:209-224
54. Misteli T, Soutoglou E (2009) The emerging role of nuclear architecture in DNA repair and genome maintenance. Nat Rev Mol Cell Biol 10:243-254
55. Seligson DB et al (2005) Global histone modi fi cation patterns predict risk of prostate cancer recurrence. Nature 435:1262-1266 (Pubitemid 40943093)
56. Kurdistani SK (2007) Histone modi fi cations as markers of cancer prognosis: a cellular view. Br J Cancer 97:1-5 (Pubitemid 47012099)
57. He LR et al (2009) Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma. BMC Cancer 9:461
58. Tzao C et al (2009) Prognostic signi fi cance of global histone modi fi cations in resected squamous cell carcinoma of the esophagus. Mod Pathol 22:252-260
59. Yu J et al (2007) A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. Cancer Res 67:10657-10663 (Pubitemid 350145890)
60. Wei Y et al (2008) Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol Carcinog 47:701-706
61. Hansen KH et al (2008) A model for transmission of the H3K27me3 epigenetic mark. Nat Cell Biol 10:1291-1300
62. Fraga MF et al (2005) Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37:391-400
63. Tryndyak VP, Kovalchuk O, Pogribny IP (2006) Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins. Cancer Biol Ther 5:65-70 (Pubitemid 43234980)
64. Pfister S et al (2008) The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma. Int J Cancer 122:1207-1213
65. Bosch-Presegue L, Vaquero A (2011) The dual role of sirtuins in cancer. Genes Cancer 2:648-662
66. Rius M, Lyko F (2011) Epigenetic cancer therapy: rationales, targets and drugs. Oncogene Dec 19. doi:10.1038/onc.2011.601
67. Pogribny IP et al (2006) Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats. Carcinogenesis 27:1180-1186 (Pubitemid 43985433)
68. Lakshmikuttyamma A, Scott SA, DeCoteau JF, Geyer CR (2010) Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition. Oncogene 29:576-588
69. Das C, Lucia MS, Hansen KC, Tyler JK (2009) CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 459:113-117
70. Williams SK, Truong D, Tyler JK (2008) Acetylation in the globular core of histone H3 on lysine-56 promotes chromatin disassembly during transcriptional activation. Proc Natl Acad Sci USA 105:9000-9005
71. Adkins MW, Williams SK, Linger J, Tyler JK (2007) Chromatin disassembly from the PHO5 promoter is essential for the recruitment of the general transcription machinery and coactivators. Mol Cell Biol 27:6372-6382 (Pubitemid 47435744)
72. Meshorer E, Misteli T (2006) Chromatin in pluripotent embryonic stem cells and differentiation. Nat Rev Mol Cell Biol 7:540-546 (Pubitemid 44036459)
73. Spivakov M, Fisher AG (2007) Epigenetic signatures of stem-cell identity. Nat Rev Genet 8:263-271 (Pubitemid 46439288)
74. Meshorer E, Gruenbaum Y (2008) Gone with the Wnt/Notch: stem cells in laminopathies, progeria, and aging. J Cell Biol 181:9-13 (Pubitemid 351519758)
75. Loh YH, Zhang W, Chen X, George J, Ng HH (2007) Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev 21:2545-2557 (Pubitemid 47607666)
76. Jepsen K et al (2007) SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron. Nature 450:415-419 (Pubitemid 350126746)
77. Frye M, Fisher AG, Watt FM (2007) Epidermal stem cells are defined by global histone modi fi cations that are altered by Myc-induced differentiation. PLoS One 2:e763
78. Ozdag H et al (2006) Differential expression of selected histone modi fi er genes in human solid cancers. BMC Genomics 7:90
79. Watanabe H et al (2008) Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells. Cancer Cell Int 8:15
80. Wang JK et al (2010) The histone demethylase UTX enables RB-dependent cell fate control. Genes Dev 24:327-332
81. van Haaften G et al (2009) Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet 41:521-523
82. Cherrier T et al (2009) p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1. Oncogene 28:3380-3389
83. Pollard PJ et al (2008) Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha. Biochem J 416:387-394
84. Scharer CD et al (2009) Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer Res 69:709-717
85. Varambally S et al (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419:624-629
86. Kondo Y et al (2008) Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 40:741-750 (Pubitemid 351748874)
87. Min J et al (2010) An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB. Nat Med 16:286-294
88. Shi Y et al (2004) Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119:941-953 (Pubitemid 40037608)
89. Wissmann M et al (2007) Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat Cell Biol 9:347-353
90. Metzger E et al (2005) LSD1 demethylates repressive histone marks to promote androgenreceptor- dependent transcription. Nature 437:436-439 (Pubitemid 41613508)
91. Metzger E et al (2010) Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4. Nature 464:792-796
92. Shi Y (2007) Histone lysine demethylases: emerging roles in development, physiology and disease. Nat Rev Genet 8:829-833 (Pubitemid 47609092)
93. Shi L et al (2011) Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis. Proc Natl Acad Sci USA 108:7541-7546
94. Lee MG, Wynder C, Cooch N, Shiekhattar R (2005) An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 437:432-435 (Pubitemid 41613507)
95. Shi YJ et al (2005) Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell 19:857-864
96. Forneris F, Binda C, Vanoni MA, Battaglioli E, Mattevi A (2005) Human histone demethylase LSD1 reads the histone code. J Biol Chem 280:41360-41365 (Pubitemid 41832193)
97. Forneris F et al (2006) A highly speci fi c mechanism of histone H3-K4 recognition by histone demethylase LSD1. J Biol Chem 281:35289-35295 (Pubitemid 46036567)
98. Cai C et al (2011) Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-speci fi c demethylase 1. Cancer Cell 20:457-471
99. Yosef N, Regev A (2011) Impulse control: temporal dynamics in gene transcription. Cell 144:886-896
100. Alenghat T et al (2008) Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature 456(7224):997-1000
101. Mohn F, Schubeler D (2009) Genetics and epigenetics: stability and plasticity during cellular differentiation. Trends Genet 25:129-136
102. De Santa F et al (2007) The histone H3 lysine-27 demethylase Jmjd3 links in fl ammation to inhibition of polycomb-mediated gene silencing. Cell 130:1083-1094 (Pubitemid 47410272)
103. Cui Q et al (2007) A map of human cancer signaling. Mol Syst Biol 3:152
104. Dobrzynski M, Bruggeman FJ (2009) Elongation dynamics shape bursty transcription and translation. Proc Natl Acad Sci USA 106(8):2583-2588
105. Goldberg AD, Allis CD, Bernstein E (2007) Epigenetics: a landscape takes shape. Cell 128:635-638 (Pubitemid 46273578)
106. Le May N et al (2010) NER factors are recruited to active promoters and facilitate chromatin modi fi cation for transcription in the absence of exogenous genotoxic attack. Mol Cell 38:54-66
107. Metivier R et al (2008) Cyclical DNA methylation of a transcriptionally active promoter. Nature 452:45-50 (Pubitemid 351355084)
108. Kangaspeska S et al (2008) Transient cyclical methylation of promoter DNA. Nature 452:112-115 (Pubitemid 351355094)
109. Wang Q et al (2009) Androgen receptor regulates a distinct transcription program in androgen- independent prostate cancer. Cell 138:245-256
110. Hu M et al (2005) Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 37:899-905 (Pubitemid 41077119)
111. Orimo A, Weinberg RA (2006) Stromal fi broblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5:1597-1601 (Pubitemid 44285243)
112. Li L, Neaves WB (2006) Normal stem cells and cancer stem cells: the niche matters. Cancer Res 66:4553-4557
113. Feinberg AP, Ohlsson R, Henikoff S (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet 7:21-33 (Pubitemid 41828945)
114. Vita M, Henriksson M (2006) The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol 16:318-330 (Pubitemid 44311040)
115. Fernandez PC et al (2003) Genomic targets of the human c-Myc protein. Genes Dev 17:1115-1129 (Pubitemid 36534986)
116. Adhikary S, Eilers M (2005) Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6:635-645 (Pubitemid 41081267)
117. Guccione E et al (2006) Myc-binding-site recognition in the human genome is determined by chromatin context. Nat Cell Biol 8:764-770
118. Bernstein BE et al (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125:315-326
119. Secombe J, Li L, Carlos L, Eisenman RN (2007) The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth. Genes Dev 21:537-551 (Pubitemid 46409469)
120. Secombe J, Eisenman RN (2007) The function and regulation of the JARID1 family of histone H3 lysine 4 demethylases: the Myc connection. Cell Cycle 6:1324-1328 (Pubitemid 47327965)
121. Suzuki C et al (2007) Identi fi cation of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer. Mol Cancer Ther 6:542-551 (Pubitemid 46332456)
122. Ogasawara S et al (2010) Accelerated expression of a Myc target gene Mina53 in aggressive hepatocellular carcinoma. Hepatol Res 40:330-336
123. Komiya K et al (2010) Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells. J Cancer Res Clin Oncol 136:465-473
124. Watt FM, Frye M, Benitah SA (2008) MYC in mammalian epidermis: how can an oncogene stimulate differentiation? Nat Rev Cancer 8:234-242 (Pubitemid 351301841)
125. Li H, Kim JH, Koh SS, Stallcup MR (2004) Synergistic effects of coactivators GRIP1 and beta-catenin on gene activation: cross-talk between androgen receptor and Wnt signaling pathways. J Biol Chem 279:4212-4220 (Pubitemid 38199008)
126. Yang X et al (2006) Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells. Oncogene 25(24):3436-3444 (Pubitemid 43877046)
127. Campbell MJ, Elstner E, Holden S, Uskokovic M, Koef fl er HP (1997) Inhibition of proliferation of prostate cancer cells by a 19-nor-hexa fl uoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin. J Mol Endocrinol 19:15-27 (Pubitemid 27345239)
128. Degenhardt T, Matilainen M, Herzig KH, Dunlop TW, Carlberg C (2006) The insulin-like growth factor binding protein 1 gene is a primary target of peroxisome proliferator-activated receptors. J Biol Chem 281(51):39607-39619 (Pubitemid 46041920)
129. Khanim FL et al (2004) Altered SMRT levels disrupt vitamin D(3) receptor signalling in prostate cancer cells. Oncogene 23:6712-6725 (Pubitemid 39280003)
130. Kubota T et al (1998) 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells. Cancer Res 58:3370-3375 (Pubitemid 28371078)
131. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP (1996) Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10:142-153 (Pubitemid 26049905)
132. Palmer HG et al (2004) The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med 10:917-919 (Pubitemid 39273731)
133. Saramaki A, Banwell CM, Campbell MJ, Carlberg C (2006) Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res 34:543-554 (Pubitemid 43240242)
134. Thorne J, Campbell MJ (2008) The vitamin D receptor in cancer. Proc Nutr Soc 67:115-127 (Pubitemid 351543394)
135. Hendriksen PJ et al (2006) Evolution of the androgen receptor pathway during progression of prostate cancer. Cancer Res 66:5012-5020 (Pubitemid 43844921)
136. Taneja SS et al (2004) ART-27, an androgen receptor coactivator regulated in prostate development and cancer. J Biol Chem 279:13944-13952 (Pubitemid 38468927)
137. Ross-Innes CS et al (2012) Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481(7381):389-393
138. Ceschin DG et al (2011) Methylation speci fi es distinct estrogen-induced binding site repertoires of CBP to chromatin. Genes Dev 25:1132-1146
139. Welboren WJ et al (2009) ChIP-Seq of ERalpha and RNA polymerase II de fi nes genes differentially responding to ligands. EMBO J 28:1418-1428
140. Rashid SF et al (2001) Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexa fl uoride analogs in combination with either sodium butyrate or trichostatin A. Oncogene 20:1860-1872 (Pubitemid 32458696)
141. Abedin SA et al (2009) Elevated NCOR1 disrupts a network of dietary-sensing nuclear receptors in bladder cancer cells. Carcinogenesis 30(3):449-456
142. Lin RJ et al (1998) Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391:811-814 (Pubitemid 28099682)
143. Banwell CM et al (2006) Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells. Clin Cancer Res 12:2004-2013
144. Ting HJ, Bao BY, Reeder JE, Messing EM, Lee YF (2007) Increased expression of corepressors in aggressive androgen-independent prostate cancer cells results in loss of 1alpha,25- dihydroxyvitamin D3 responsiveness. Mol Cancer Res 5:967-980 (Pubitemid 47416673)
145. Tomlins SA et al (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310:644-648 (Pubitemid 41528150)
146. Anderson SP et al (2004) Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor {alpha}, retinoid X receptor and liver X receptor in mouse liver. Mol Pharmacol 66(6):1440-1452 (Pubitemid 39564771)
147. Bookout AL et al (2006) Anatomical pro fi ling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126:789-799 (Pubitemid 44233630)
148. Handschin C, Meyer UA (2005) Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR. Arch Biochem Biophys 433:387-396 (Pubitemid 39592793)
149. Xia X et al (2009) Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc Natl Acad Sci USA 106:4260-4265
150. Malik S, Roeder RG (2010) The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nat Rev Genet 11:761-772
151. Xu J, Wu RC, O'Malley BW (2009) Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nat Rev Cancer 9:615-630
152. Taatjes DJ, Marr MT, Tjian R (2004) Regulatory diversity among metazoan co-activator complexes. Nat Rev Mol Cell Biol 5:403-410 (Pubitemid 38579477)
153. Perissi V, Jepsen K, Glass CK, Rosenfeld MG (2010) Deconstructing repression: evolving models of co-repressor action. Nat Rev Genet 11:109-123
154. Battaglia S, Maguire O, Campbell MJ (2010) Transcription factor co-repressors in cancer biology: roles and targeting. Int J Cancer 126:2511-2519
155. Anzick SL et al (1997) AIB1, a steroid receptor coactivator ampli fi ed in breast and ovarian cancer. Science 277:965-968 (Pubitemid 27366683)
156. Demarest SJ et al (2002) Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. Nature 415:549-553 (Pubitemid 34130612)
157. Zhao C et al (2003) Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis. Cancer 98:18-23 (Pubitemid 36741120)
158. Doi M, Hirayama J, Sassone-Corsi P (2006) Circadian regulator CLOCK is a histone acetyltransferase. Cell 125:497-508
159. Esteyries S et al (2008) NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid leukemia. Leukemia 22:663-665 (Pubitemid 351386746)
160. Horlein AJ et al (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404
161. Chen JD, Evans RM (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457
162. Li J et al (2000) Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J 19:4342-4350 (Pubitemid 30623745)
163. Yu C et al (2005) The nuclear receptor corepressors NCoR and SMRT decrease PPARgamma transcriptional activity and repress 3T3-L1 adipogenesis. J. Biol, Chem
164. Jepsen K, Gleiberman AS, Shi C, Simon DI, Rosenfeld MG (2008) Cooperative regulation in development by SMRT and FOXP1. Genes Dev 22:740-745 (Pubitemid 351439105)
165. Tiefenbach J et al (2006) SUMOylation of the corepressor N-CoR modulates its capacity to repress transcription. Mol Biol Cell 17:1643-1651 (Pubitemid 44011582)
166. Surjit M et al (2011) Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145:224-241
167. Heikkinen S et al (2011) Nuclear hormone 1{alpha},25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res 39(21):9181-9193
168. Muller-Tidow C et al (2010) Pro fi ling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia. Blood 116:3564-3571
169. Hoemme C et al (2008) Chromatin modi fi cations induced by PML-RARalpha repress critical targets in leukemogenesis as analyzed by ChIP-Chip. Blood 111:2887-2895
170. Minucci S et al (2000) Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation. Mol Cell 5:811-820
171. Girault I et al (2003) Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen. Clin Cancer Res 9:1259-1266 (Pubitemid 36418375)
172. Zhang Z et al (2005) NCOR1 mRNA is an independent prognostic factor for breast cancer. Cancer Lett 237(1):123-129
173. Kim JY, Son YL, Lee YC (2009) Involvement of SMRT corepressor in transcriptional repression by the vitamin D receptor. Mol Endocrinol 23:251-264
174. Chang TH, Szabo E (2002) Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung. Clin Cancer Res 8:1206-1212 (Pubitemid 35177376)
175. Battaglia S et al (2010) Elevated NCOR1 disrupts PPAR signaling in prostate cancer and forms a targetable epigenetic lesion. Carcinogenesis 31(9):1650-1660
176. Bau D et al (2011) The three-dimensional folding of the alpha-globin gene domain reveals formation of chromatin globules. Nat Struct Mol Biol 18:107-114
177. Li Q, Barkess G, Qian H (2006) Chromatin looping and the probability of transcription. Trends Genet 22:197-202
178. Eskiw CH, Rapp A, Carter DR, Cook PR (2008) RNA polymerase II activity is located on the surface of protein-rich transcription factories. J Cell Sci 121:1999-2007 (Pubitemid 352015197)
179. Mitchell JA, Fraser P (2008) Transcription factories are nuclear subcompartments that remain in the absence of transcription. Genes Dev 22:20-25
180. Hu Q et al (2008) Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proc Natl Acad Sci USA 105:19199-19204
181. Yoon HG, Chan DW, Reynolds AB, Qin J, Wong J (2003) N-CoR mediates DNA methylationdependent repression through a methyl CpG binding protein Kaiso. Mol Cell 12:723-734 (Pubitemid 37222492)
182. Yegnasubramanian S et al (2004) Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res 64:1975-1986 (Pubitemid 38339443)
183. Asatiani E et al (2005) Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer. Cancer Res 65:1164-1173 (Pubitemid 40270140)
184. Fujita N et al (2003) Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression. J Biol Chem 278:24132-24138 (Pubitemid 36830249)
185. Esteve PO et al (2006) Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. Genes Dev 20:3089-3103
186. Cheng X, Blumenthal RM (2010) Coordinated chromatin control: structural and functional linkage of DNA and histone methylation. Biochemistry 49:2999-3008
187. Freitag M, Hickey PC, Khlafallah TK, Read ND, Selker EU (2004) HP1 is essential for DNA methylation in Neurospora. Mol Cell 13:427-434 (Pubitemid 38229814)
188. Birney E et al (2007) Identi fi cation and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447:799-816 (Pubitemid 46920138)
189. Schulte JH et al (2009) Lysine-speci fi c demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy. Cancer Res 69:2065-2071
190. Graham JS, Kaye SB, Brown R (2009) The promises and pitfalls of epigenetic therapies in solid tumours. Eur J Cancer 45:1129-1136